Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
McKesson
McKinsey
Chinese Patent Office
Medtronic
Colorcon
Novartis
Fuji
US Army
Accenture

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200565

« Back to Dashboard
NDA 200565 describes PHENYTOIN, which is a drug marketed by Vistapharm, Wockhardt, Taro, Epic Pharma Llc, Mylan Pharms Inc, Actavis Mid Atlantic, Warner Chilcott, Marsam Pharms Llc, Fresenius Kabi Usa, West-ward Pharms Int, Aurobindo Pharma Ltd, Smith And Nephew, Solopak, Hospira, Watson Labs, Pharmeral, Acella Pharms Llc, and Luitpold, and is included in twenty-four NDAs. It is available from twelve suppliers. Additional details are available on the PHENYTOIN profile page.

The generic ingredient in PHENYTOIN is phenytoin sodium. There are nineteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.

Summary for NDA: 200565

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 200565

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHENYTOIN
phenytoin
TABLET, CHEWABLE;ORAL 200565 ANDA Taro Pharmaceuticals U.S.A., Inc 51672-4146 51672-4146-1 100 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-1)
PHENYTOIN
phenytoin
TABLET, CHEWABLE;ORAL 200565 ANDA Taro Pharmaceuticals U.S.A., Inc 51672-4146 51672-4146-3 1000 TABLET, CHEWABLE in 1 BOTTLE (51672-4146-3)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength50MG
Approval Date:Apr 17, 2014TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
McKesson
Johnson and Johnson
Citi
Julphar
US Department of Justice
US Army
UBS
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot